Clinical Studies Sponsored by Heron Therapeutics

Phase 2 Herniorrhaphy Study for Opioid Elimination

Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen

Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1)

Safety Study of Repeat Doses of SUSTOL in Adults

A Phase 2, Two-Part Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy

Extended Delivery of Bupivacaine Study in Herniorrhaphy

Pediatric Postoperative Analgesia Herniorrhaphy Study

Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)

A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC

Bunionectomy Study for Postoperative Analgesia (EPOCH 1)

Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia

Phase 2B Upper Extremity Nerve Block Study

Bupivacaine HCl PK and Safety in Augmentation Mammoplasty

Phase 2 Bunionectomy HTX-011 Administration Study

Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy

HTX-011 Administration Study in Planned Caesarean Section Procedure

Herniorrhaphy Study for Opioid Elimination

Dose-Escalation Study of HTX-034 Following Bunionectomy

Evaluation of the Efficacy and Safety of HTX-011 for Postoperative Analgesia Following Abdominoplasty Surgery

APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer

A Phase I Study of the Effects of APF530 Exposure, Granisetron and Moxifloxacin